The AHA Scientific Sessions 2022 are a gathering of scientific and clinical professionals with the aim of cardiovascular health improvement through global education. 

The research undertaken by Dr Jorg Taubel et al. will be presented during the conference: First-in-Human in vivo CRISPR/Cas9 Editing of the TTR Gene by NTLA-2001 in Patients with Transthyretin Amyloidosis with Cardiomyopathy

The topics presented at the AHA Scientific Sessions 2022 are advocating scientific discovery, clinical practise and more with global speakers, sessions on digital health, leadership education for healthcare leaders and more. 

To find out more AHA 2022 Registration | AHA Scientific Sessions 2022

Latest news

Richmond Pharmacology appoints Sandra Johnson as Director of Commercial Project Management

September 19, 2022
We are delighted to announce that Sandra Johnson will join Richmond Pharmacology as its new Director for Commercial Project Management
Read more

How telemonitoring can revolutionise the way we treat patients – Tom York

November 17, 2022
Richmond Pharmacology always searches for the most innovative processes to improve clinical trials and the patients’ experiences and treatments.
Read more


JPW2022 (Japan Basic and Clinical Pharmacology Week 2022)

30 November – 3 December 2022
This event will be the 96th Annual Meeting of the Japanese Pharmacological Society and the 43rd Annual Meeting of the Japanese Society of Clinical Pharmacology. 
View event